Found: 25
Select item for more details and to access through your institution.
Very low carbohydrate (ketogenic) diets in type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2431, doi. 10.1111/dom.14837
- By:
- Publication type:
- Article
Predictors of haemoglobin levels and of changes in these levels, focusing on anaemia and polycythaemia after administration of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2469, doi. 10.1111/dom.14836
- By:
- Publication type:
- Article
Effect of renin‐angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2443, doi. 10.1111/dom.14838
- By:
- Publication type:
- Article
Are angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2465, doi. 10.1111/dom.14835
- By:
- Publication type:
- Article
Increased prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes and hypertension: The SWEET international database.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2420, doi. 10.1111/dom.14834
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
A comparison of the effectiveness and safety of insulin glargine 300 U/ml versus 100 U/ml in children and adolescents with newly diagnosed type 1 diabetes: A retrospective, observational, short‐term study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2474, doi. 10.1111/dom.14839
- By:
- Publication type:
- Article
Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2297, doi. 10.1111/dom.14830
- By:
- Publication type:
- Article
Preclinical pharmacology of RA15127343: In vitro and in vivo activity of a novel ultralong‐acting basal insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2411, doi. 10.1111/dom.14827
- By:
- Publication type:
- Article
Repetitive transcranial magnetic stimulation: A potential therapeutic option for obesity in a patient with Prader‐Willi syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2478, doi. 10.1111/dom.14833
- By:
- Publication type:
- Article
TOTUM‐63, a plant‐based polyphenol‐rich extract, improves glycaemic control in subjects with prediabetes or early stage newly‐diagnosed type 2 diabetes in a randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2331, doi. 10.1111/dom.14817
- By:
- Publication type:
- Article
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2283, doi. 10.1111/dom.14829
- By:
- Publication type:
- Article
Canagliflozin, mental health adverse events and diabetes: Exploratory analysis of the CREDENCE trial and CANVAS Program.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2459, doi. 10.1111/dom.14832
- By:
- Publication type:
- Article
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2309, doi. 10.1111/dom.14815
- By:
- Publication type:
- Article
Separate and combined effect of visit‐to‐visit glycaemic variability and mean fasting blood glucose level on all‐cause mortality in patients with type 2 diabetes: A population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2400, doi. 10.1111/dom.14826
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2281, doi. 10.1111/dom.14436
- Publication type:
- Article
Cover Image, Volume 24, Issue 12.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 1, doi. 10.1111/dom.14114
- By:
- Publication type:
- Article
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2391, doi. 10.1111/dom.14825
- By:
- Publication type:
- Article
Evaluation of continuous glucose monitoring‐derived person‐specific HbA1c in the presence and absence of complications in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2383, doi. 10.1111/dom.14824
- By:
- Publication type:
- Article
T he R eal‐World O bservational P rospective Study of H ealth Outcomes with Dulaglut i de and Liraglutide in Patients with Typ e 2 Diabete s (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2373, doi. 10.1111/dom.14823
- By:
- Publication type:
- Article
Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2364, doi. 10.1111/dom.14822
- By:
- Publication type:
- Article
Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2353, doi. 10.1111/dom.14821
- By:
- Publication type:
- Article
Hepatic steatosis and advanced fibrosis are independent predictors of mortality in acute myocardial infarction without standard modifiable risk factors.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2454, doi. 10.1111/dom.14820
- By:
- Publication type:
- Article
Revisiting 'intensive' blood glucose control: A causal directed acyclic graph‐guided systematic review of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2341, doi. 10.1111/dom.14819
- By:
- Publication type:
- Article
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open‐label, crossover, active‐comparator FIORE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2319, doi. 10.1111/dom.14816
- By:
- Publication type:
- Article